The FDA just approved Foundayo (orforglipron), a once-daily GLP-1 pill for weight loss with no injections, no fasting, and no food restrictions. Dr. Dagher breaks down how it works, what the clinical trials show, and the key drug interactions every patient needs to know before starting it.

The American Heart Association just released its biggest cholesterol update in nearly a decade. Here's what it means for your heart health, explained by a Pasadena primary care and preventative medicine doctor.